Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SUJANA BIOTECH, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-11-15 to 2019-08-14
Current total value of award: $783488
Description: DEVELOPING AN ANTI-THROMBOTIC MONOCLONAL ANTIBODY (MAB) WITH IMPROVED SAFETY AND EFFICACY, VITA 2